High-dose doxorubicin, dexrazoxane, and GM-CSF in malignant mesothelioma: a phase II study—Cancer and Leukemia Group B 9631
Kosty, Michael P, Herndon, James E, Vogelzang, Nicholas J, Kindler, Hedy L, Green, Mark RVolume:
34
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(01)00250-1
Date:
November, 2001
File:
PDF, 86 KB
english, 2001